Apnar Pharma Lp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APNAR PHARMA LP, and what generic and branded alternatives to APNAR PHARMA LP drugs are available?
APNAR PHARMA LP has five approved drugs.
Drugs and US Patents for Apnar Pharma Lp
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apnar Pharma Lp | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 077491-002 | Oct 23, 2006 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Apnar Pharma Lp | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 087128-001 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Apnar Pharma Lp | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET;ORAL | 075584-002 | Feb 7, 2000 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.